急性心肌梗死早期生化标志物的研究进展

摘要

As the morbidity and the mortality of acute myocardial infarction( AMI )in China are increasing rapidly, early biomarkers used for early diagnosisand treatment have become more and more important. The current major early biomarkers such as myoloperoxidas,C-reactive protein,matrix metallo-proteases, isch-emiamodified albumin, heart-type fatty acid binding protein and cardiac troponin have important diagnostic value in AMI diagnosis and treatment.%随着我国急性心肌梗死(AMI)的患病率和病死率日趋增高,早期生化标志物对AMI的早期诊断、积极治疗越来越重要,目前主要的AMI早期生化标志物,如髓过氧化物酶、C反应蛋白、基质金属蛋白酶、缺血修饰白蛋白、心肌型脂肪酸结合蛋白和心肌肌钙蛋白等在AMI诊断和治疗过程中具有重要的诊断价值.